The unintended consequences of clinical trials regulations.
Alex McMahon and colleagues critique the International Conference on Harmonisation (ICH) guidance on good clinical practice (GCP), arguing that it is having a disastrous effect on noncommerical randomized clinical trials in Europe.
Main Authors: | Alex D McMahon, David I Conway, Tom M Macdonald, Gordon T McInnes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-11-01
|
Series: | PLoS Medicine |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19918557/?tool=EBI |
Similar Items
-
The unintended consequences of interregionalism
by: Burcu Ermeydan
Published: (2022-12-01) -
Unintended Consequences of Remittance
by: Adediran Daniel Ikuomola
Published: (2015-09-01) -
Saving lives: Long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
by: Gordon T McInnes
Published: (2000-06-01) -
Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
by: Gordon T McInnes
Published: (2000-06-01) -
Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin
by: Jessica Fraeyman, et al.
Published: (2015-12-01)